Cilian McCabe, PhD Eli Lilly & Company

Prior to joining Eli Lilly & Co. in 2007, Cillian graduated with a PhD in Molecular Medicine from NUI, Galway, Ireland and gained considerable experience in the areas of cell culture and gene therapy viral vector production platforms.  Since joining Eli Lilly & Co., Cillian has held a number of technical support roles in the US and Ireland supporting Process Development, Commercialization and Commercial Supply. In  Cillian’s current role, as a drug substance control strategy steward for multiple molecules he provides technical oversight to new product introductions and commercial supply.